PAPER Fei M, Jianghua W, Rujuan M, Wei Z, Qian W
SEARCH RESULTS
331159 RESULTS
PAPER Ohno-Matsui K
Parallel findings in age-related macular degeneration and Alzheimer's disease.
Prog Retin Eye Res. 2011 Jul;30(4):217-38. PubMed: 21440663PAPER Krishnamurti S, Drake L, King J
Neural network modeling of central auditory dysfunction in Alzheimer's disease.
Neural Netw. 2011 Aug;24(6):646-51. PubMed: 21441013PAPER Ortega A, Rincón Á, Jiménez-Aliaga KL, Bermejo-Bescós P, Martín-Aragón S, Molina MT, Csákÿ AG
Synthesis and evaluation of arylquinones as BACE1 inhibitors, β-amyloid peptide aggregation inhibitors, and destabilizers of preformed β-amyloid fibrils.
Bioorg Med Chem Lett. 2011 Apr 15;21(8):2183-7. PubMed: 21441028PAPER Majumdar A, Capetillo-Zarate E, Cruz D, Gouras GK, Maxfield FR
Degradation of Alzheimer's amyloid fibrils by microglia requires delivery of ClC-7 to lysosomes.
Mol Biol Cell. 2011 May 15;22(10):1664-76. PubMed: 21441306PAPER Treiber KA, Carlson MC, Corcoran C, Norton MC, Breitner JC, Piercy KW, Deberard MS, Stein D, Foley B, Welsh-Bohmer KA, Frye A, Lyketsos CG, Tschanz JT
Cognitive stimulation and cognitive and functional decline in Alzheimer's disease: the cache county dementia progression study.
J Gerontol B Psychol Sci Soc Sci. 2011 Jul;66(4):416-25. PubMed: 21441386PAPER Taylor RC, Dillin A
Aging as an event of proteostasis collapse.
Cold Spring Harb Perspect Biol. 2011 May;3(5) PubMed: 21441594PAPER Sutherland GT, Siebert GA, Kril JJ, Mellick GD
Knowing me, knowing you: can a knowledge of risk factors for Alzheimer's disease prove useful in understanding the pathogenesis of Parkinson's disease?
J Alzheimers Dis. 2011;25(3):395-415. PubMed: 21441655PAPER Hegde ML, Hegde PM, Rao KS, Mitra S
Oxidative genome damage and its repair in neurodegenerative diseases: function of transition metals as a double-edged sword.
J Alzheimers Dis. 2011;24 Suppl 2:183-98. PubMed: 21441656PAPER Gong QH, Shi XR, Hong ZY, Pan LL, Liu XH, Zhu YZ
A new hope for neurodegeneration: possible role of hydrogen sulfide.
J Alzheimers Dis. 2011;24 Suppl 2:173-82. PubMed: 21441657PAPER Plangár I, Zádori D, Klivényi P, Toldi J, Vécsei L
Targeting the kynurenine pathway-related alterations in Alzheimer's disease: a future therapeutic strategy.
J Alzheimers Dis. 2011;24 Suppl 2:199-209. PubMed: 21441658PAPER Larner AJ, Marson AG
Epileptic seizures in Alzheimer's disease: another fine MESS?
J Alzheimers Dis. 2011;25(3):417-9. PubMed: 21441660PAPER Resenberger UK, Harmeier A, Woerner AC, Goodman JL, Müller V, Krishnan R, Vabulas RM, Kretzschmar HA, Lindquist S, Hartl FU, Multhaup G, Winklhofer KF, Tatzelt J
The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication.
EMBO J. 2011 May 18;30(10):2057-70. PubMed: 21441896PAPER Jo J, Whitcomb DJ, Olsen KM, Kerrigan TL, Lo SC, Bru-Mercier G, Dickinson B, Scullion S, Sheng M, Collingridge G, Cho K
Aβ(1-42) inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β.
Nat Neurosci. 2011 May;14(5):545-7. PubMed: 21441921PAPER Kashani MS, Tavirani MR, Talaei SA, Salami M
Aqueous extract of lavender (Lavandula angustifolia) improves the spatial performance of a rat model of Alzheimer's disease.
Neurosci Bull. 2011 Apr;27(2):99-106. PubMed: 21441971Current Filters
No filters selected